Pedro Henrique Barbosa Pereira

3PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 19, 2025
Targeting PRC2 Enhances the Cytotoxic Capacity of Anti-CD19 CAR T Cells against Hematologic Malignancies.

Maria Leticia Rodrigues Carvalho, Clara de Oliveira Andrade, Mariela Pires Cabral-Piccin

|May 25, 2023
Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas.

Gabriela Sarti Kinker, Glauco Akelinghton Freire Vitiello, Ariane Barros Diniz

|May 28, 2022
Immune Checkpoint Blockade via PD-L1 Potentiates More CD28-Based than 4-1BB-Based Anti-Carbonic Anhydrase IX Chimeric Antigen Receptor T Cells.

Najla Santos Pacheco de Campos, Adriano de Oliveira Beserra, Pedro Henrique Barbosa Pereira

Pageof 1